Pharmaceutical formulations comprising voriconazole and processes for preparation thereof

Details for Australian Patent Application No. 2009335460 (hide)

Owner Xu, Y. NANJING CAVENDISH BIOENGINEERING TECHNOLOGY CO., LTD.

Inventors Xu, Yongxiang

Agent Pegasus IP

Pub. Number AU-B-2009335460

PCT Pub. Number WO2010/075801

Priority 200810192985.7 31.12.08 CN

Filing date 31 December 2009

Wipo publication date 8 July 2010

Acceptance publication date 19 July 2012

International Classifications

A61K 31/506 - not condensed and containing further heterocyclic rings

A61K 9/19 Medicinal preparations characterised by special physical form - lyophilised

A61K 47/34 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 31/10 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/075801 Priority application(s): WO2010/075801

19 July 2012 Application Accepted

  Published as AU-B-2009335460

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335539-Digital processing method and device of large or medium-size sand mold

2009335405-Use of an APL peptide for the treatment of inflammatory bowel disease and type 1 diabetes